← Mechanisms of action
EPOR
SINGLE PROTEINHomo sapiens
Preferred name: Erythropoietin receptor ChEMBL ↗
Linked proteins
Drugs acting on this target (8)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| darbepoetin alfa (aranesp) | Agonist | approved | Recombinant protein | EPOR agonist |
| darbepoetin beta | Agonist | experimental | Recombinant protein | EPOR agonist |
| epoetin (Epogen) | Agonist | approved | Recombinant protein | EPOR agonist |
| erythropoetin beta | Agonist | experimental | Recombinant protein | EPOR agonist |
| methoxy polyethylene glycol-epoetin beta (Mircera) | Agonist | approved | Recombinant protein | Erythropoietin receptor agonist |
| peginesatide (Omontys) | Agonist | approved | Peptide | EPOR agonist |
| pegmolesatide | Agonist | experimental | Peptide | EPOR agonist |
| ranibizumab (lucentis) | Inhibitor | approved | mAb | EPOR inhibitor |